Targeted-TERS detection of integrin receptors on human cancer cells

Area of Science:

• Biochemistry
• Cell Biology
• Biophysics

Background:

• Membrane receptors regulate cellular functions, making them crucial targets for cancer prognosis and therapy.
• Understanding ligand-receptor binding chemistry at the cell membrane is vital but technologically challenging.
• Integrin receptors, involved in tumor cell migration and proliferation, bind to arginine-glycine-aspartate (RGD) ligands.

Purpose of the Study:

• To develop and demonstrate a novel technology for molecularly probing ligand-receptor binding chemistry on intact cell membranes.
• To investigate the binding interactions of integrin receptors with RGD-containing ligands.
• To assess the potential of tip-enhanced Raman scattering (TERS) for differentiating similar membrane receptors.

Main Methods:

• Utilized tip-enhanced Raman scattering (TERS) microscopy.
• Studied the binding interactions between integrin receptors and a cyclic-RGDfC peptide ligand.
• Applied the methodology to intact cell membranes to analyze receptor-ligand interactions.

Main Results:

• Successfully detected integrin receptors and characterized their binding chemistry with cyclic-RGDfC ligand using TERS.
• Demonstrated the ability of TERS to differentiate between two structurally similar integrins based on their RGD ligand binding sites.
• Showcased the specificity and sensitivity of the TERS approach for analyzing molecular interactions in live cells.

Conclusions:

• Tip-enhanced Raman scattering (TERS) is a powerful technology for studying ligand-receptor interactions at the molecular level on live cell membranes.
• This TERS methodology offers potential for differentiating between closely related membrane receptors and understanding their binding dynamics.
• The findings highlight the utility of TERS for advancing cancer therapeutics and molecular diagnostics by providing insights into cell surface receptor behavior.